IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.
Inducible degrader of the low density lipoprotein receptor (IDOL), is an E3 ubiquitin ligase that negatively modulates low density lipoprotein receptor (LDL-R) expression. Genome-wide association studies (GWAS) indicated that genetic variants in IDOL gene contributes to variation in LDL-C plasma levels and the detailed analysis of a specific locus resulted in the identification of the functional common single nucleotide polymorphism (SNP) rs9370867 (c.G1025A, p.N342S) associates with increased LDL-R degradation and increased LDL-C levels. These findings, however, were not confirmed in two other independent cohorts and no data about the impact of this variant on atherosclerosis progression and cardiovascular risk are available. Aim of this study was to investigate the association between a functional variant in IDOL and atherosclerosis progression in an Italian general population. 1384 subjects enrolled in the PLIC study (Progression of Lesions in the Intima of Carotid) were genotyped by Q-PCR allelic discrimination and the association with anthropometric parameters, plasma lipids and the carotid intima media thickness (cIMT) and the impact on cardiovascular disease (CVD) incidence were investigated. The N342S variant was not associated with changes of the plasma lipid profile among GG, AG or AA carriers, including total cholesterol (249±21, 249±19 and 248±21 mg/dl respectively), LDL-C (158±25, 161±22 and 160±23 mg/dL), cIMT (0.74±0.14, 0.75±0.17 and 0.77±0.15 mm) and CVD incidence. In agreement, the expression of LDLR and the uptake of LDL was similar in macrophages derived from GG and AA carriers. Taken together our findings indicate that the N342S variant does not impact plasma lipid profile and is not associated with atherosclerosis progression and CVD in the general population, suggesting that other variants in the IDOL gene might be functionally linked with cholesterol metabolism.
Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Ashish
A
Dhyani
Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; I.R.C.C.S MultiMedica, Milan, Italy.
Gianpaolo
G
Tibolla
SISA Center for the Study of Atherosclerosis, Bassini Hospital, Cinisello B., Italy.
Andrea
A
Baragetti
SISA Center for the Study of Atherosclerosis, Bassini Hospital, Cinisello B., Italy.
Katia
K
Garlaschelli
SISA Center for the Study of Atherosclerosis, Bassini Hospital, Cinisello B., Italy.
Fabio
F
Pellegatta
I.R.C.C.S MultiMedica, Milan, Italy; SISA Center for the Study of Atherosclerosis, Bassini Hospital, Cinisello B., Italy.
Liliana
L
Grigore
Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; SISA Center for the Study of Atherosclerosis, Bassini Hospital, Cinisello B., Italy; The Blizard Institute, Centre for Diabetes, Barts and The London School of Medicine & Dentistry, Queen Mary University, London, United Kingdom.
Giuseppe Danilo
GD
Norata
Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy; I.R.C.C.S MultiMedica, Milan, Italy.
Alberico Luigi
AL
Catapano
D000368:Aged; D050197:Atherosclerosis / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism; D059168:Carotid Intima-Media Thickness; D008078:Cholesterol, LDL / Q000097:blood / Q000235:genetics; D005260:Female; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D059748:Proteolysis; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases / Q000235:genetics* / Q000378:metabolism
D008078:Cholesterol, LDL; C573412:LDLR protein, human; D011973:Receptors, LDL; C403126:MYLIP protein, human; D044767:Ubiquitin-Protein Ligases